Online yoga eased cough in lung fibrosis patients, YES-IPF trial finds

A peer-reviewed study of online yoga for people with idiopathic pulmonary fibrosis (IPF), a scarring disease of the lungs, was made available in the journal Respiratory Medicine on Wednesday, October 14, 2026. The trial, called YES-IPF (Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis), was run at the Center for Interstitial Lung Diseases at UW Medical Center in Seattle, United States. Its authors report that a virtual yoga programme was feasible and well tolerated, and that patients in the yoga group scored better on several cough and quality-of-life measures than patients who received usual care alone. The authors call the findings exploratory and say a larger trial is needed.

Idiopathic pulmonary fibrosis is a long-term lung disease in which the tissue around the air sacs thickens and stiffens, so breathing becomes harder over time. "Idiopathic" means the cause is not known. The disease mostly affects older adults, and its daily burden is heavy: a dry, persistent cough, breathlessness during ordinary tasks, tiredness and anxiety. Medicines can slow the decline in lung function, but they do little for the cough and the loss of quality of life that patients describe as the hardest part of living with the illness.

That gap is where gentle, supervised movement and breathing practice have attracted interest. Pulmonary rehabilitation, which combines exercise training and education, is already a standard recommendation for many lung patients, but it usually means travelling to a clinic several times a week, which is hard for frail, older and breathless people. YES-IPF tested whether yoga delivered over video could be a practical alternative. The trial was carried out by virtual means, and its home-based format is one of its most useful findings: participants could join from their own homes, and nearly all of them stayed in the study to the end.

For readers who follow Yoga as part of the Ayush systems, the study is a useful example of how yoga is increasingly tested in hospital settings abroad with standard medical questionnaires, randomisation and trial registration. It also shows the limits of such early work. The benefits were measured by what patients reported about their own symptoms, not by improvements in the lungs themselves. The authors are careful to describe the results as exploratory.

Short-term: The publication gives lung specialists and patients evidence that an online, seated yoga programme can be run safely for older people with IPF, and that most participants will keep attending. Doctors who already suggest breathing practice or relaxation for symptom relief now have a peer-reviewed pilot trial to point to, with a clear description of what the sessions contained.

Long-term: The authors' call for a larger trial is the key next step. A bigger, multi-centre study could test whether the cough and quality-of-life gains hold up, whether they last beyond 12 weeks, and whether they bring any change in lung function or exercise capacity. If they do, virtual yoga could become an option alongside conventional pulmonary rehabilitation, especially for patients who cannot travel.

Who is affected: People living with idiopathic pulmonary fibrosis and their carers, lung specialists and rehabilitation teams, yoga teachers who work with older or chronically ill people, and researchers studying yoga as a complementary therapy.

Questions and Answers